Liverton; Nigel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liverton; Nigel.The latest application filed is for "fused heteroaryl derivatives as orexin receptor antagonists".
Company Profile
6.26.28
- Liverton; Nigel - Harleysville PA
Patent Activity
| Patent | Date |
|---|---|
| Fused heteroaryl derivatives as orexin receptor antagonists Grant 10,526,336 - Kuduk , et al. J | 2020-01-07 |
| Oxazole orexin receptor antagonists Grant 10,435,398 - Kuduk , et al. O | 2019-10-08 |
| Piperidine oxadiazole and thiadiazole orexin receptor antagonists Grant 10,308,645 - Liverton , et al. | 2019-06-04 |
| Heteroaryl orexin receptor antagonists Grant 10,239,838 - Kuduk , et al. | 2019-03-26 |
| Pyrazole orexin receptor antagonists Grant 10,227,336 - Liverton , et al. | 2019-03-12 |
| Hydroxmethyl piperidine orexin receptor antagonists Grant 10,214,535 - Kuduk , et al. Feb | 2019-02-26 |
| Fused Heteroaryl Derivatives As Orexin Receptor Antagonists App 20180370973 - Kuduk; Scott D. ; et al. | 2018-12-27 |
| Amidoethyl azole orexin receptor antagonists Grant 10,155,750 - Kuduk , et al. Dec | 2018-12-18 |
| Pyrrolidine orexin receptor antagonists Grant 10,150,751 - Kuduk , et al. Dec | 2018-12-11 |
| Pyrazole, triazole and tetrazole orexin receptor antagonists Grant 10,010,539 - Liverton , et al. July 3, 2 | 2018-07-03 |
| Ethyldiamine orexin receptor antagonists Grant 10,011,595 - Kim , et al. July 3, 2 | 2018-07-03 |
| 5,5-bicyclic oxazole orexin receptor antagonists Grant 9,987,255 - Kuduk , et al. June 5, 2 | 2018-06-05 |
| 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists Grant 9,938,276 - Kim , et al. April 10, 2 | 2018-04-10 |
| Methyl oxazole orexin receptor antagonists Grant 9,920,038 - Kuduk , et al. March 20, 2 | 2018-03-20 |
| 5,5-Bicyclic Oxazole Orexin Receptor Antagonists App 20170368035 - Kuduk; Scott D. ; et al. | 2017-12-28 |
| Ethyldiamine Orexin Receptor Antagonists App 20170355692 - Kim; Ronald M. ; et al. | 2017-12-14 |
| Pyrrolidine Orexin Receptor Antagonists App 20170342052 - Kuduk; Scott D. ; et al. | 2017-11-30 |
| Oxazole orexin receptor antagonists Grant 9,828,368 - Liverton , et al. November 28, 2 | 2017-11-28 |
| Piperidine Isoxazole And Isothiazole Orexin Receptor Antagonists App 20170327490 - LIVERTON; NIGEL ; et al. | 2017-11-16 |
| Oxazole Orexin Receptor Antagonists App 20170320865 - KUDUK; SCOTT D. ; et al. | 2017-11-09 |
| Hydroxmethyl Piperidine Orexin Receptor Antagonists App 20170320884 - Kuduk; Scott D. ; et al. | 2017-11-09 |
| Amidoethyl Azole Orexin Receptor Antagonists App 20170320856 - Kuduk; Scott D. ; et al. | 2017-11-09 |
| 6,5-bicyclic Octahydropyrrolopyridine Orexin Receptor Antagonists App 20170320874 - Kim; Ronald M. ; et al. | 2017-11-09 |
| Pyrazole, Triazole And Tetrazole Orexin Receptor Antagonists App 20170319560 - LIVERTON; NIGEL ; et al. | 2017-11-09 |
| Piperidine Oxadiazole And Thiadiazole Orexin Receptor Antagonists App 20170313693 - LIVERTON; NIGEL ; et al. | 2017-11-02 |
| Pyrazole Orexin Receptor Antagonists App 20170313684 - LIVERTON; NIGEL ; et al. | 2017-11-02 |
| Heteroaryl Orexin Receptor Antagonists App 20170260136 - Kuduk; Scott D. ; et al. | 2017-09-14 |
| Methyl Oxazole Orexin Receptor Antagonists App 20170260177 - Kuduk; Scott D. ; et al. | 2017-09-14 |
| Thiazole orexin receptor antagonists Grant 9,695,163 - Liverton , et al. July 4, 2 | 2017-07-04 |
| Thiazole Orexin Receptor Antagonists App 20160185768 - LIVERTON; NIGEL ; et al. | 2016-06-30 |
| Oxazole Orexin Receptor Antagonists App 20160176858 - LIVERTON; NIGEL ; et al. | 2016-06-23 |
| HCV NS3 protease inhibitors Grant 9,328,138 - Rudd , et al. May 3, 2 | 2016-05-03 |
| Hcv Ns3 Protease Inhibitors App 20140296136 - Rudd; Michael T. ; et al. | 2014-10-02 |
| Isoquinolinone potassium channel inhibitors Grant 8,338,449 - Trotter , et al. December 25, 2 | 2012-12-25 |
| Isoquinolinone Potassium Channel Inhibitors App 20100256698 - Trotter; B. Wesley ; et al. | 2010-10-07 |
| Isoquinoline potassium channel inhibitors Grant 7,763,614 - Isaacs , et al. July 27, 2 | 2010-07-27 |
| Isoquinolinone potassium channel inhibitors Grant 7,723,352 - Trotter , et al. May 25, 2 | 2010-05-25 |
| 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists Grant 7,452,893 - Thompson , et al. November 18, 2 | 2008-11-18 |
| Isoquinoline potassium channel inhibitors App 20070054892 - Isaacs; Richard ; et al. | 2007-03-08 |
| 4-Cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists App 20070037829 - Thompson; Wayne ; et al. | 2007-02-15 |
| Isoquinolinone potassium channel inhibitors App 20070027177 - Trotter; B. Wesley ; et al. | 2007-02-01 |
| 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists App 20050054658 - Thompson, Wayne ; et al. | 2005-03-10 |
| Carbocyclic potassium channel inhibitors Grant 6,632,836 - Baker , et al. October 14, 2 | 2003-10-14 |
| Fibrinogen receptor antagonists Grant 5,821,241 - Claremon , et al. October 13, 1 | 1998-10-13 |
| N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides Grant 5,691,332 - Claremon , et al. November 25, 1 | 1997-11-25 |
| 2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzo diazepines Grant 5,658,901 - Claremon , et al. August 19, 1 | 1997-08-19 |
| Antiarrhythmic benzodiazepines Grant 5,595,990 - Baldwin , et al. January 21, 1 | 1997-01-21 |
| Fibrinogen receptor antagonists Grant 5,389,631 - Claremon , et al. February 14, 1 | 1995-02-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 